You're Probably Not Magnesium Deficient. You Might Still Be Short.
Around half of us eat too little magnesium — yet no ordinary blood test can tell you whether you're truly short. That gap, between intake and proof, is the whole business model.
The £45 electrolyte habit, audited.The powder industry sells you sodium — the hard-outcome trials point the other way. Plus: is "structured" water anything?
The Salt Argument Is Really an Argument About Who You Are
Two camps, both right about their own person and wrong to generalise. The methodology fight, the sweat-sodium maths, and a decision map you can actually find yourself on.
The Cold Plunge Works by Cancelling the Adaptation You Came For
Less soreness doesn't buy more growth — the trials already tested the objection everyone raises. Here's the answer, and the decision map by training goal
The Blueprint Audit: What 70 Pills a Day Actually Buys
70 pills, three that earn their place - The famous ageing-clock number isn't the win — the boring biomarker underneath it is. We audited the stack. Read on
The pellet clinics already misreading the data 🔍5,246 men. 27,347 women. Two hormone files quietly rewritten — and the £400/month pellet clinics who are about to ride the rebound.
Three hormone routes graded across men and women. The £600-per-visit pellet model audited. Plus the FDA label change the WHI generation deserved twenty years ago.
Five trials in people who don't move at all, what they actually showed, and the only condition under which the wooden box does anything that resembles training.
One best-selling gummy carried 347% of what the label claimed. What actually works is in the same aisle — at a sixth of the dose, for a fifth of the price.
The $4bn sleep aisle is a con - 0.3mg beats 10mg and nobody’s told you
The Sleep Stage Ageing Takes First— and the Pill That Makes It Worse
Why the most restorative sleep stage quietly disappears, why the most-prescribed sleep drug accelerates the loss, and what the evidence says actually protects it.
We graded Lion’s Mane, creatine, and phosphatidylserine. One is worth buying. The other two have better marketing than evidence. Plus: a £95/month nootropic subscription dismantled
